AIM IMMUNOTECH INC
AIM·00901B303·US·Common Stock·Healthcare - Biotechnology-13D/G
AIM (AIM IMMUNOTECH INC) is held by 12 institutional investors as of Q1 2026. Largest holders: GEODE CAPITAL MANAGEMENT, LLC ($17,501), XTX Topco Ltd ($12,045), JANE STREET GROUP, LLC ($11,727). Net institutional sentiment: Bullish.
12
Holders
(1 Elite)
$55,007
Total Value
78% (9)
Consensus
7 buying - 2 selling
13F: Insider & Congress:
Who's Trading
ActivistMPMitchell P. Kopin0.0%May 27, 2026
ActivistOAOrca Capital AG9.9%May 12, 2026
InsiderEKEquels Thomas KBuy $823.58Jun 13, 2025
InsiderEKEquels Thomas KBuy $50KApr 11, 2025
InsiderKDKELLNER TED DBuy $50KApr 11, 2025
InsiderMMMITCHELL WILLIAM MBuy $5KApr 11, 2025
InsiderEKEquels Thomas KBuy $3KApr 4, 2025
InsiderRIRodino Peter W IIIBuy $43.5Apr 4, 2025
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer